Need Help?

PhIP-seq of Japanese subjects with SLE

Bacteriophage Immunoprecipitation Sequencing (PhIP-Seq) datasets of three eHHV-6B-positive SLE patients (three technical replicates), six eHHV-6B-negative SLE patients (three technical replicates), and a negative control lacking sera or plasma (12 technical replicates; Illumina NextSeq) and sequencing data of HHV-6 peptide phage library (two technical replicates; Illumina NextSeq).

Request Access

PhIP-seq data of eHHV-6B-positive Japanese subjects with SLE (N=3) and eHHV-6B-negative Japanese subjects with SLE (N=6) were collected at Osaka University and related institutes.

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom Osaka University grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: Osaka University and the collaborators listed in Appendix I responsible for the development, organization, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. Osaka University: Department of Statistical Genetics, Osaka University Graduate School of Medicine 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organization for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify Osaka University within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify Osaka University prior to any significant changes to the protocol for the Project. 14. The User Institution will notify Osaka University as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. Osaka University may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than Osaka University. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of Japan and shall be subject to the exclusive jurisdiction of the Japanese courts.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001007955 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00008608978 fastq.gz 45.0 MB
EGAF00008608979 fastq.gz 67.9 MB
EGAF00008608980 fastq.gz 59.3 MB
EGAF00008608981 fastq.gz 90.4 MB
EGAF00008608982 fastq.gz 40.5 MB
EGAF00008608983 fastq.gz 61.4 MB
EGAF00008608984 fastq.gz 48.3 MB
EGAF00008608985 fastq.gz 74.1 MB
EGAF00008608986 fastq.gz 42.3 MB
EGAF00008608987 fastq.gz 61.9 MB
EGAF00008608988 fastq.gz 26.2 MB
EGAF00008608989 fastq.gz 37.2 MB
EGAF00008608990 fastq.gz 17.1 MB
EGAF00008608991 fastq.gz 24.6 MB
EGAF00008608992 fastq.gz 24.2 MB
EGAF00008608993 fastq.gz 36.3 MB
EGAF00008608994 fastq.gz 11.7 MB
EGAF00008608995 fastq.gz 16.8 MB
EGAF00008608996 fastq.gz 15.5 MB
EGAF00008608997 fastq.gz 22.2 MB
EGAF00008608998 fastq.gz 18.7 MB
EGAF00008608999 fastq.gz 26.6 MB
EGAF00008609000 fastq.gz 24.2 MB
EGAF00008609001 fastq.gz 35.3 MB
EGAF00008609002 fastq.gz 27.3 MB
EGAF00008609003 fastq.gz 39.6 MB
EGAF00008609004 fastq.gz 25.8 MB
EGAF00008609005 fastq.gz 38.2 MB
EGAF00008609006 fastq.gz 32.7 MB
EGAF00008609007 fastq.gz 46.9 MB
EGAF00008609008 fastq.gz 29.9 MB
EGAF00008609009 fastq.gz 43.2 MB
EGAF00008609010 fastq.gz 33.0 MB
EGAF00008609011 fastq.gz 47.9 MB
EGAF00008609012 fastq.gz 23.1 MB
EGAF00008609013 fastq.gz 33.0 MB
EGAF00008609014 fastq.gz 24.8 MB
EGAF00008609015 fastq.gz 35.9 MB
EGAF00008609016 fastq.gz 22.6 MB
EGAF00008609017 fastq.gz 32.4 MB
EGAF00008609018 fastq.gz 29.1 MB
EGAF00008609019 fastq.gz 41.8 MB
EGAF00008609020 fastq.gz 17.9 MB
EGAF00008609021 fastq.gz 25.4 MB
EGAF00008609022 fastq.gz 26.9 MB
EGAF00008609023 fastq.gz 38.6 MB
EGAF00008609024 fastq.gz 23.0 MB
EGAF00008609025 fastq.gz 33.0 MB
EGAF00008609026 fastq.gz 33.2 MB
EGAF00008609027 fastq.gz 46.6 MB
EGAF00008609028 fastq.gz 45.3 MB
EGAF00008609029 fastq.gz 66.3 MB
EGAF00008609030 fastq.gz 45.6 MB
EGAF00008609031 fastq.gz 66.0 MB
EGAF00008609032 fastq.gz 22.6 MB
EGAF00008609033 fastq.gz 33.2 MB
EGAF00008609034 fastq.gz 28.8 MB
EGAF00008609035 fastq.gz 42.0 MB
EGAF00008609036 fastq.gz 22.9 MB
EGAF00008609037 fastq.gz 33.6 MB
EGAF00008609038 fastq.gz 21.6 MB
EGAF00008609039 fastq.gz 30.6 MB
EGAF00008609040 fastq.gz 59.9 MB
EGAF00008609041 fastq.gz 88.4 MB
EGAF00008609042 fastq.gz 61.4 MB
EGAF00008609043 fastq.gz 89.4 MB
EGAF00008609044 fastq.gz 29.4 MB
EGAF00008609045 fastq.gz 42.2 MB
EGAF00008609046 fastq.gz 28.3 MB
EGAF00008609047 fastq.gz 41.5 MB
EGAF00008609048 fastq.gz 23.6 MB
EGAF00008609049 fastq.gz 33.0 MB
EGAF00008609050 fastq.gz 38.3 MB
EGAF00008609051 fastq.gz 56.0 MB
EGAF00008609052 fastq.gz 27.2 MB
EGAF00008609053 fastq.gz 38.6 MB
EGAF00008609054 fastq.gz 29.7 MB
EGAF00008609055 fastq.gz 42.4 MB
EGAF00008609056 fastq.gz 20.5 MB
EGAF00008609057 fastq.gz 29.1 MB
EGAF00008609058 fastq.gz 29.9 MB
EGAF00008609059 fastq.gz 43.8 MB
EGAF00008609060 fastq.gz 25.2 MB
EGAF00008609061 fastq.gz 36.6 MB
EGAF00008609062 fastq.gz 29.9 MB
EGAF00008609063 fastq.gz 42.3 MB
86 Files (3.2 GB)